profit from every TRY 100 of sales.
TRY 0TRY 100
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
TRY 5.04+9.33% today
-54.0% since Dec 22, 25
1-year low TRY 3.331-year high TRY 13.27
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay TRY 27.82 for every TRY 1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi vs. similar companies
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi grows the fastest of these 5 and is priced in the middle for its profits.
| Company | Profit from TRY 100 of sales | Sales growth a year | Price per TRY 1 of profit |
|---|---|---|---|
| Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi | 27.8× · Fair price | ||
 Merck KGaA | 24.9× · Fair price | ||
 Takeda Pharmaceutical | 102.5× · Very expensive | ||
 Galderma Group | 86.9× · Very expensive | ||
 Teva Pharmaceutical Industries | 36.8× · Expensive |
AI analysis
An AI analyst reads Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 27.8×
- –
- 12.57
- 3.5×
- 1.2×
- 45.2×
- –
- 2.2%
- 3.6%
- –
Profitability
- 21.0%
- 12.9%
- 4.2%
- –
- 13.4%
- 9.3%
- –
- –
- –
- –
Growth
- +21.7%
- +2.2%
- –
- –
- +6.0%
Financial health
- 1.0×
- 0.30
- –
- 2.6×
- 1.27
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 16%of 952
Top 41%of 883
Bottom 47%of 601
Top 25%of 888
Top 42%of 987
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
34No pass
Benjamin Graham
44No pass
Philip Fisher
34No pass
Peter Lynch
28No pass
Joel Greenblatt
34No pass
Charlie Munger
26No pass
Terry Smith
21No pass
Questions about Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
Is Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi a good stock to buy?
A business with weak numbers at a fair price. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi AI analysis
What does Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi do?
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. It is in Drug Manufacturers - Specialty & Generic.
Is Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi stock halal?
Yes. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi passes our halal screen: its business is permitted and its debt is 15% of its market value, under the 30% limit. How we check
Who are Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi's competitors?
The largest listed companies in the same industry are Merck KGaA, Takeda Pharmaceutical, Galderma Group and Teva Pharmaceutical Industries. The peers table on this page compares their profit, growth and price with Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.